Gainers
- 1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its existing portfolio.
- Perfect Corp (NYSE: PERF) shares jumped 54.5% to $17.00.
- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) gained 38% to $1.60 after the company announced an agreement with Janssen for the evaluation of three Sonnet product candidates.
- Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 30% to $7.37 after the company announced the results from its BioLexa Phase 1b clinical trial in adult patients with mild-to-moderate atopic dermatitis met the primary and secondary endpoints for safety and efficacy.
- Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 19.2% to $6.02.
- Terran Orbital Cor (NYSE: LLAP) gained 17.4% to $3.0050 after the company received a $100 million investment from Lockheed Martin (NYSE:LMT).
- TrueCar, Inc. (NASDAQ: TRUE) surged 15.7% to $1.7598. JP Morgan upgraded TrueCar from Underweight to Overweight.
- Renalytix Plc (NASDAQ: RNLX) rose 14% to $1.96 after reporting FY22 results.
- Aravive, Inc. (NASDAQ: ARAV) gained 13.9% to $1.2073. Aravive recently announced approximately $41.5 million private placement financing.
- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) gained 13.2% to $4.3048.
- Presto Automation, Inc. (NASDAQ: PRST) jumped 12.5% to $1.8911.
- Berkeley Lights, Inc. (NASDAQ: BLI) gained 12.3% to $2.3250. Berkeley Lights is expected to report Q3 financial results on November 8, 2022.
- Silicom Ltd. (NASDAQ: SILC) jumped 11.7% to $44.55 following upbeat Q3 results.
- Anterix Inc. (NASDAQ: ATEX) gained 11.5% to $38.43.
- AMTD Digital Inc. (NYSE: HKD) rose 12.6% to $23.05.
- Healthcare Triangle, Inc. (NASDAQ: HCTI) jumped 10.2% to $0.2713.
- Wave Life Sciences Ltd. (NASDAQ: WVE) gained 9.1% to $4.93.
- First Solar, Inc. (NASDAQ: FSLR) surged 7.6% to $142.81 after B of A Securities maintained a Buy rating on the stock and raised its price target from $138 to $165.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers
- Quanergy Systems, Inc. (NYSE: QNGY) shares dipped 67.6% to $1.07 after the company priced its $16.7 million offering.
- Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) dropped 51.5% to $4.36 after the FDA Oncologic Drugs Advisory Committee voted Y-mAbs did not provide sufficient evidence to conclude its treatment improves overall survival.
- Argo Blockchain plc (NASDAQ: ARBK) fell 47.1% to $1.0418 after the company announced it believes its previously announced non-binding LOI with a strategic investor to raise $27 million via a subscription for ordinary shares will no longer be consummated. Roth Capital downgraded Argo Blockchain from Neutral to Sell and lowered the price target from $2 to $0.25.
- TuSimple Holdings Inc. (NASDAQ: TSP) fell 42.2% to $3.6450 following a media report stating the company is being investigated over ties to a Chinese startup. TuSimple board terminated CEO, President, and Chief Technology Officer Dr. Xiaodi Hou from his position.
- Ucommune International Ltd (NASDAQ: UK) dropped 41.1% to $1.06.
- Quotient Limited (NASDAQ: QTNT) dropped 34.8% to $0.0838. Quotient announced intent to effect 1-for-40 reverse stock split November 22.
- Instil Bio, Inc. (NASDAQ: TIL) fell 26.7% to $3.85 after the company voluntarily paused enrollment of its ongoing clinical trials.
- T Stamp Inc. (NASDAQ: IDAI) declined 23.1% to $0.6999.
- Tantech Holdings Ltd (NASDAQ: TANH) dropped 22.2% to $0.1281 after the company announced a reverse stock split.
- ESSA Pharma Inc. (NASDAQ: EPIX) dipped 22.1% to $3.4350 after the company announced Janssen Research and Development is suspending enrollment into the Phase 1 clinical study of EPI-7386 with apalutamide or EPI-7386 with abiraterone acetate plus prednisone.
- Golden Sun Education Group Limited (NASDAQ: GSUN) dropped 17.7% to $21.37.
- Inventiva S.A. (NYSE: IVA) fell 17.7% to $4.80. Inventiva said AbbVie (NYSE:ABBV) communicated that they decided to stop the development of cedirogant (ABBV-157) for the treatment of autoimmune disease.
- HeartCore Enterprises, Inc. (NASDAQ: HTCR) declined 15.5% to $1.57.
- Ensysce Biosciences, Inc. (NASDAQ: ENSC) dropped 14.6% to $3.3150. Ensysce Biosciences announced topline results from a human abuse potential (HAP) study for PF614.
- Starry Group Holdings, Inc. (NYSE: STRY) dipped 11.8% to $0.2559. Citigroup (NYSE:C) downgraded Starry Group Holdings from Neutral to Sell and lowered the price target from $3.75 to $0.25.
- Hyperfine, Inc. (NASDAQ: HYPR) fell 10.4% to $0.8601.
- Edible Garden AG Incorporated (NASDAQ: EDBL) fell 9.9% to $0.6201. Edible Garden recently added three new, greenhouse grown, salad kits to its list of Stock Keeping Units (SKU).
- Fangdd Network Group Ltd. (NASDAQ: DUO) fell 9.4% to $1.7582 after jumping around 27% on Friday.
- DoorDash, Inc. (NYSE: DASH) dipped 8.8% to $42.88.
- Advanced Human Imaging Limited (NASDAQ: AHI) dropped 7.9% to $0.4883.
- Global Payments Inc. (NYSE: GPN) fell 7.6% to $115.79 following downbeat quarterly earnings.
- Newell Brands Inc. (NASDAQ: NWL) dropped 7.5% to $13.93. Barclays (LON:BARC) downgraded Newell Brands from Equal-Weight to Underweight and lowered the price target from $16 to $11.
- ON Semiconductor Corporation (NASDAQ: ON) fell 6% to $63.52 after the company reported Q3 financial results and issued Q4 guidance.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.